XtalPi Partners with Eli Lilly in Groundbreaking $250M Collaboration, Utilizing AI and Robotics

Cambridge, MA, May 30, 2023 (PRNewswire) -- XtalPi, a leading pharmaceutical technology company, has joined forces with Eli Lilly and Company in a cutting-edge collaboration leveraging artificial intelligence (AI) and automation to discover innovative therapeutics. With XtalPi's state-of-the-art AI drug discovery platform and robotics capabilities, this partnership aims to deliver first-in-class compounds for undisclosed targets, revolutionizing the drug development process and advancing patient care.

Read full article here.